Hospitalist Doctors in Flagstaff, AZ Accepting Medicare

7 Hospitalist doctors found. Showing 1 - 7

Dr. Sanya Aysha Kayani, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920    Fax: 928-214-2925

Brandon Robert Thomas, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-779-3366

Dr. Christine Marie Kneisel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920    Fax: 928-214-2925

Edward G Paul, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2920 N 4th St, Flagstaff, AZ 86004 Phone: 928-522-9400    Fax: 928-774-4808

Dr. Marian Lacy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-213-6235    Fax: 928-213-6292

Audrey Lee, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920    Fax: 928-214-2925

Dr. Matthew Randolph, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920

News Archive

North Dakota, Kansas join list of states considering further abortion restrictions

An abortion clinic fights to stay open amid new proposed restrictions in North Dakota while Kansas lawmakers spar over new proposed restrictions on using state money for the procedure in that state.

B cells in breast milk can produce HIV-neutralizing antibodies

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS.

Z-endoxifen may provide better treatment for women with estrogen positive breast cancer

A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate that Z-endoxifen, co-developed by Mayo Clinic Cancer Center and the National Cancer Institute, may provide a new and better treatment for some women with estrogen positive breast cancer and, in particular, for those women who do not respond to tamoxifen and aromatase inhibitors.

Non-O blood type - the most important risk factor for venous thromboembolism

The non-O ABO blood type is the most important risk factor for venous thromboembolism (blood clots in veins), making up 20% of attributable risk for the condition, according to a new study in CMAJ (Canadian Medical Association Journal).

Spero Health launched to tackle the rising opioid crisis

Spero Health, Inc., a newly formed healthcare organization specializing in local, affordable, outpatient care for individuals suffering from substance use disorder, announced that it has acquired investment growth capital to meet the demand in communities across the country for high-quality, comprehensive and integrated addiction treatment services.

Read more Medical News

› Verified 8 days ago